Phase Holographic Imaging (PHI) is currently preparing fluorescence units for its first users. The HoloMonitor add-on fluorescence unit enables medical research laboratories to analyze the all-important genetic activity of individual cells as they multiply in a cell incubator - without the detrimental effects associated with conventional fluorescence microscopy. Until January 20, 2022, researchers had no choice but to harm their valuable cells each time they were imaged.

However, most of the fluorescence images during an experiment are taken to track cell movement, not to observe the much slower genetic changes. The combination of imaging techniques allows HoloMonitor to track cell movement using frequent but harmless holographic imaging rather than harmful fluorescence imaging. This unique ability leads to a dramatic reduction of the number of required fluorescence images, which allows HoloMonitor users to minimize or eliminate the undesired toxic effects when characterizing individual cells and their genetic activity.

The result is more cost-effective and reliable research outcomes.